EMA Marketing Authorization of New Drugs in September 2025

Shots: The EMA’s CHMP has granted approvals to 5 Biologics and 5 new chemical entities in September 2025, leading to treatments for patients and advances in the healthcare industry The major highlighted drug, Merck’s Enflonsia, has Adopted Positive Opinion for RSV Prevention in Infants PharmaShots has compiled a list of 9 drugs that have been…

ByDipanshu DixitOctober 21, 2025

Announcements

PharmaShots Ranked Among the Top 10 in Feedspot’s “45 Best Indian Pharma Blogs & Websites 2025”

PharmaShots is proud to announce that we have been ranked 6th among the “45 Best Indian Pharma Blogs and Websites in 2025” by Feedspot, a leading platform that curates the best online content across industries. This recognition underscores our commitment to delivering concise, credible, and high-impact biopharma and healthcare insights to our global audience. Being featured alongside some of…

BySaurabh ChaubeyOctober 18, 2025

WEEKLY SNAPSHOT

PharmaShots Weekly Snapshots (Oct 13, 2025 – Oct 17, 2025)   

This week, PharmaShots’ news was all about the updates on Clinical Trials, Regulatory, Pharma, MedTech, M&A, DigiHealth, Animal Health, and Biosimilars. Check out our full report below: Arcus Biosciences Reports the P-II (EDGE-Gastric) Trial Data on Domvanalimab + Yutuo (Zimberelimab) for Gastroesophageal Adenocarcinomas Read More: Arcus Biosciences HUTCHMED Reports the P-II/III (FRUSICA-2) Trial Data of Fruquintinib…

ByRidhi RastogiOctober 17, 2025

INSIGHTS+

Know Your Investor: Google Ventures (October’25 Edition)

Shots: Welcome to the October edition of Know Your Investor, spotlighting leading investors shaping the future of healthcare and life sciences This month, we feature Google Ventures (GV), the venture capital arm of Alphabet. GV actively invests across seed to growth-stage companies, spanning sectors such as software, internet, healthcare, life sciences, and artificial intelligence For…

ByPrince GiriOctober 16, 2025

THOUGHTSPOT

Trends in Biopharma: SPAC Market Resurgence

A Special Purpose Acquisition Company (SPAC) is a “blank check” shell company created to raise funds through an IPO to finance a merger or acquisition. In 2020 and 2021, SPAC activity surged dramatically, raising over $83B across 248 IPOs in 2020 and $160B across 613 IPOs in 2021. Healthcare-focused SPACs alone contributed $11.1B in 2020…

BySaurabh ChaubeyOctober 15, 2025

EXCLUSIVE

Exclusive: A Stimulating Dialogue with Edmund Ben Ami, Co-Founder & CEO of NeuraLight

Shots: Given the high variability and subjectivity of traditional clinical scales, there is an urgent need for objective biomarkers to assess CNS disease progression more reliably NeuraLight is at the forefront of precision neurology, developing objective and sensitive biomarkers that bring greater accuracy and consistency to CNS research In this exclusive conversation, Edmund…

BySaurabh ChaubeyOctober 14, 2025

THOUGHTSPOT

The Ultimate Guide to Safer Night Driving: Tips, Tricks, and Tools

Driving at night can be challenging due to reduced visibility and glare from headlights. Implementing effective strategies and using the right tools can enhance safety and comfort during nighttime driving. Nighttime driving often presents difficulties that can affect your safety. The lack of natural light reduces visibility, making it harder to see obstacles or changes…

ByJohn CunninghamOctober 14, 2025

VIEWPOINTS

Enhancing R&D Prowess in Oncology: Denis R. Beckford-Vera from Champions Oncology in Conversation with PharmaShots

Shots: The complexity of human physiology continues to challenge drug development, as conventional models often fail to provide critical insights, resulting in high attrition rates Champions Oncology bridges this gap through patient-derived xenograft and ex vivo platforms built from real tumors, integrated with radiolabeled compounds for deeper R&D insights Denis R. Beckford-Vera, Head of Radiopharmacology…

BySaurabh ChaubeyOctober 13, 2025

CXO TALKS

CXO Talks: Josh Wittner from Gene By Gene in a Riveting Conversation with PharmaShots

Shots: In this captivating episode of the CXO Talks Podcast, PharmaShots sits down with Josh Wittner, President, North America at Gene By Gene, to explore the company’s evolution and impact in the field of genetic testing Gene By Gene, a leading commercial genetic testing company, delivers cutting-edge genetic data services spanning a broad range of…

ByAditya SinghOctober 13, 2025

WEEKLY SNAPSHOT

PharmaShots Weekly Snapshots (Oct 06, 2025 – Oct 10, 2025)  

This week, PharmaShots’ news was all about the updates on Clinical Trials, Regulatory, Pharma, MedTech, M&A, DigiHealth, Animal Health, and Biosimilars. Check out our full report below:   AstraZeneca and Daiichi Sankyo Report P-III (TROPION-Breast02) Trial Results of Datroway for Triple-Negative Breast Cancer Read More: AstraZeneca and Daiichi Sankyo AstraZeneca Reports P-III (Bax24) Trial Data on…

ByRidhi RastogiOctober 10, 2025

EMA Marketing Authorization of New Drugs in September 2025

PharmaShots Ranked Among the Top 10 in Feedspot’s “45 Best Indian Pharma Blogs & Websites 2025”

PharmaShots Weekly Snapshots (Oct 13, 2025 – Oct 17, 2025)

Know Your Investor: Google Ventures (October’25 Edition)

Trends in Biopharma: SPAC Market Resurgence

Exclusive: A Stimulating Dialogue with Edmund Ben Ami, Co-Founder & CEO of NeuraLight

The Ultimate Guide to Safer Night Driving: Tips, Tricks, and Tools

Enhancing R&D Prowess in Oncology: Denis R. Beckford-Vera from Champions Oncology in Conversation with PharmaShots

CXO Talks: Josh Wittner from Gene By Gene in a Riveting Conversation with PharmaShots

PharmaShots Weekly Snapshots (Oct 06, 2025 – Oct 10, 2025)

Contact US

OUR INFORMATION

FOLLOW US